Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,841.25
    -35.80 (-0.45%)
     
  • Bitcoin USD

    64,967.73
    +3,282.45 (+5.32%)
     
  • CMC Crypto 200

    1,334.62
    +21.99 (+1.71%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,395.50
    -2.50 (-0.10%)
     
  • Crude Oil

    82.57
    -0.16 (-0.19%)
     
  • 10-Yr Bond

    4.6470
    0.0000 (0.00%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

How’s Endo International Positioned in December?

How’s Endo International Positioned in December?

How's Endo International Positioned in December? Endo International (ENDP) is a global specialty pharmaceutical company with a focus on generic and branded pharmaceuticals. Endo International generated total revenues of $745.47 million in the third quarter of 2018 as compared with $786.89 million in the comparable period of 2017.